ROME, June 11 (Reuters) - The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had taken the shot died from a blood clot.
Camilla Canepa died on Thursday aged 18 after being given the vaccine on May 25, triggering a storm of controversy in Italy over the Anglo-Swedish brand being given to adults of all ages despite previously-raised medical concerns.
"AstraZeneca will only be used for people over 60," the country's special COVID commissioner Francesco Figliuolo told reporters at a news conference. (Reporting By Gavin Jones, editing by Angelo Amante)
Our Standards: The Thomson Reuters Trust Principles.